ZHANG Qian,CHENG Xin-Ru,SHENG Guang-Yao. Serum NT-proBNP levels in neonates with severe asphyxia and the effects of nalmefene on the NT-proBNP levels[J]. CJCP, 2010, 12(11): 922-923.
［4］Hammerer-Lercher A, Mair J, Tews G, Puschendorf B, Sommer R. N-terminal pro-B-type natriuretic peptide concentrations are markedly higher in the umbilical cord blood of newborns than in their mothers［J］. Clin Chem, 2005, 51(5): 913-915.
［5］Mir TS, Laux R, Hellwege HH, Liedke B, Heinze C, von Buelow H, et al. Plasma concentrations of aminoterminal pro atrial natriuretic peptide and aminoterminal pro brain natriuretic peptide in healthy neonates: marked and rapid increase after birth［J］. Pediatrics, 2003, 112(4): 896-899.
［7］Johns MC, Stephenson C. Amino-terminal pro-B-type natriuretic peptide testing in neonatal and pediatric patients［J］. Am J Cardiol, 2008, 101(3A): 76-81.
［9］Liang CS, Imai N, Stone CK, Woolf PD, Kawashima S, Tuttle RR. The role of endogenous opioids in congestive heart failure: effects of nalmefene on systemic and regional hemodynamics in dogs［J］. Circulation, 1987, 75 (2): 443-451.
［10］Lutsep HL, Clark WM. Neuroprotection in acute ischemic stroke. Current status and future potential［J］. Drugs R D, 1999, 1(1): 3-8.
